Beth P. Hecht
Board Member
Iterum Therapeutics plc (ITRMF)General Counsel
Xeris Biopharma Holdings, Inc. (XERS)Equibles does not estimate personal net worth.
Get an email with a short summary when Iterum Therapeutics plc publishes a filing, an earnings call transcript or a press release.
Get ITRMF alertsAbout Beth P. Hecht
Beth P. Hecht is recorded as Board Member at Iterum Therapeutics plc (ITRMF) and General Counsel at Xeris Biopharma Holdings, Inc. (XERS) since October 5, 2021. The newest filing on record that lists Beth P. Hecht as Board Member at Iterum Therapeutics plc (ITRMF) is dated July 29, 2025. The proxy statement of Xeris Biopharma Holdings, Inc. reports total compensation of $1,895,274 for Beth P. Hecht in fiscal 2025, including a base salary of $517,089. Disclosed compensation is on record for 5 fiscal years. Iterum Therapeutics plc is classified in the Biotechnology industry within the Healthcare sector. Xeris Biopharma Holdings, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Iterum Therapeutics plc includes Brenton K. Ahrens (Chairman), David Kelly (Chairman), Beth Hecht (Board Member) and 5 others.
Affiliation history
-
Current
2021-10-05–present
-
Current
Start not stated–present
Last confirmed July 29, 2025
-
Xeris Biopharma Holdings, Inc. (XERS)
Proxy statement
CurrentStart not stated–present
Last confirmed April 23, 2026
Company network
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
2021-10-05–present
Leadership on record at Iterum Therapeutics plc
- Brenton K. Ahrens Chairman
- David Kelly Chairman
- Beth Hecht Board Member
- Corey Fishman Board Member
- David G. Kelly Board Member
- Joseph J. Whalen Board Member
- Michael Dunne, M.D. Board Member
- Michael W. Dunne Board Member
Leadership on record at Xeris Biopharma Holdings, Inc.
- John P. Shannon CEO, Board Member
- John Shannon CEO, Chairman, COO, Board Member
- Marla S. Persky Chairman
- Steven M. Pieper CFO
- Kevin McCulloch COO
- Dawn Halkuff Board Member
- Jeffrey W. Sherman Board Member
- John H. Johnson Board Member
- John Johnson Board Member
- Menassie Taddese Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | $517,089 | $1,895,274 |
| 2024 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | $491,732 | $2,612,825 |
| 2023 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | $460,601 | $1,129,443 |
| 2022 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | $442,214 | $1,270,561 |
| 2021 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | $417,183 | $1,424,994 |
Recent activity
No call appearances or filed executive changes recorded yet.